Abstract:Regression is a key feature of neurodevelopmental disorders such as Autism Spectrum Disorder, Fragile X Syndrome and Rett syndrome (RTT). RTT is caused by mutations in the X-linked gene Methyl CpG-Binding Protein 2 (MECP2). It is characterized by an early period of typical development with subsequent regression of previously acquired motor and speech skills in girls. The syndromic phenotypes are individualistic and dynamic over time. Thus far, it has been difficult to capture these dynamics and syndromic heterogeneity in the preclinical Mecp2-heterozygous female mouse model (Het). The emergence of computational neuroethology tools allows for robust analysis of complex and dynamic behaviors to model endophenotypes in pre-clinical models. Towards this first step, we utilized DeepLabCut, a marker-less pose estimation software to quantify trajectory kinematics, and multidimensional analysis to characterize behavioral heterogeneity in Het in the previously benchmarked, ethologically relevant social cognition task of pup retrieval. We report the identification of two distinct phenotypes of adult Het: Het that display a delay in efficiency in early days and then improve over days like wild-type mice, and Het that regress and perform worse in later days. Furthermore, regression is dependent on age, behavioral context, and is identifiable in early days of retrieval. Together, the novel identification of two populations of Het suggests differential effects on neural circuitry, opens new avenues to investigate the underlying molecular and cellular mechanisms of heterogeneity, and design better studies for stratifying therapeutics. Significance Statement A long-standing problem in the field of neuropsychiatric disorders is the reliable identification of heterogeneous endophenotypes in animal models for the disorders. This problem has clear implications in identifying etiology and therapeutic targets. The emergence of accessible computational neuroethology tools is a powerful solution in systematic characterization of animal behaviors in resolving this heterogeneity. Using DeepLabCut and multidimensional analysis of an ethologically relevant social cognition task, we identify two distinct populations exhibiting delay in efficient behavior and regression in a female mouse model for Rett syndrome. The novel identification of two populations in genotypically-identical mice has profound implications on both etiology and personalized therapeutic approaches.

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome

Comparative profiling of white matter development in the human and mouse brain reveals volumetric deficits and delayed myelination in Angelman syndrome

Identification of key biomarkers in Angelman syndrome by a multi-cohort analysis

Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome

Multiparametric Assays Capture Sex- and Environment-Dependent Modifiers of Behavioral Phenotypes in Autism Mouse Models

Multi-parametric assays capture sex- and environment-dependent modifiers of behavioral phenotypes in autism mouse models

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

UBE3A reinstatement restores behavior and proteome in an Angelman Syndrome mouse model of Imprinting Defects

1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

Genotype–Phenotype Correlations in Angelman Syndrome

Altered circadian rhythms and sleep in a new Angelman Syndrome mouse model

Multidimensional analysis of a social behavior identifies regression and phenotypic heterogeneity in a female mouse model for Rett syndrome

Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients

An Analysis of Phenotype and Genotype in a Large Cohort of Chinese Children with Angelman Syndrome

A PSD-95 Peptidomimetic Mitigates Neurological Deficits in a Mouse Model of Angelman Syndrome.

A common computational and neural anomaly across mouse models of autism

Precision medicine in Angelman syndrome

Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome

Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model

Deficits in higher visual area representations in a mouse model of Angelman syndrome